These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5934806)

  • 1. Fate of amethopterin-resistant mutants in L1210 mouse leukemia populations.
    Hoshino A; Albrecht AM; Hutchison DJ
    Cancer Res; 1966 May; 26(5):974-8. PubMed ID: 5934806
    [No Abstract]   [Full Text] [Related]  

  • 2. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic aspects of homofolate derivatives in relation to amethopterin-resistant murine leukemia.
    Mead JA; Goldin A; Kisliuk RL; Friedkin M; Plante L; Crawford EJ; Kwok G
    Cancer Res; 1966 Nov; 26(11):2374-9. PubMed ID: 4959533
    [No Abstract]   [Full Text] [Related]  

  • 4. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 5. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 6. SELECTION OF CHROMOSOMAL VARIANT IN AMETHOPTERIN-RESISTANT SUBLINES OF LEUKEMIA L1210 WITH INCREASED LEVELS OF DIHYDROFOLATE REDUCTASE.
    BIEDLER JL; SCHRECKER AW; HUTCHISON DJ
    J Natl Cancer Inst; 1963 Sep; 31():575-601. PubMed ID: 14059004
    [No Abstract]   [Full Text] [Related]  

  • 7. ASSOCIATION OF INCREASED DIHYDROFOLATE REDUCTASE LEVELS AND CHROMOSOME ALTERATION IN AMETHOPTERIN-RESISTANT SUBLINES OF LEUKEMIA L1210.
    SCHRECKER AW; VENDITTI JM; GREENBERG NH; BIEDLER JL; ROBINSON DL; HUTCHISON DJ
    J Natl Cancer Inst; 1963 Sep; 31():557-74. PubMed ID: 14059003
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
    Thayer PS; Himmelfarb P; Roberts D
    Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential cell permeability and the basis for selective activity of methotrexate during therapy of the L1210 leukemia.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1973 Jun; 33(6):1290-4. PubMed ID: 4718678
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential biochemical alteration to antifolate resistance in L1210 leukaemia.
    Sirotnak FM; Kurita S; Sargent MG; Robinson DL; Hutchison DJ
    Nature; 1967 Dec; 216(5121):1236-7. PubMed ID: 5235641
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy.
    Wilcox WS; Schabel FM; Skipper HE
    Cancer Res; 1966 May; 26(5):1009-14. PubMed ID: 5934786
    [No Abstract]   [Full Text] [Related]  

  • 14. Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
    Strobel-Stevens JD; El Dareer SM; Trader MW; Hill DL
    Biochem Pharmacol; 1982 Oct; 31(19):3133-7. PubMed ID: 6890814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies with tetrahydrohomofolate and thymidylate synthetase from amethopterin-resistant mouse leukemia cells.
    Livingston D; Crawford EJ; Friedkin M
    Biochemistry; 1968 Aug; 7(8):2814-8. PubMed ID: 4875280
    [No Abstract]   [Full Text] [Related]  

  • 16. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
    [No Abstract]   [Full Text] [Related]  

  • 17. Amethopterin resistance in clonal lines of L1210 mouse leukemia: some associated biologic and biochemical alterations.
    Hoshino A; Albrecht AM; Biedler JL; Hutchison DJ
    Cancer Res; 1966 Jul; 26(7):1397-407. PubMed ID: 5911581
    [No Abstract]   [Full Text] [Related]  

  • 18. The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.
    Henderson ES; Adamson RH; Denham C; Oliverio VT
    Cancer Res; 1965 Aug; 25(7):1008-17. PubMed ID: 4954195
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth of L1210 mouse leukemia cells in vitro.
    Hutchison DJ; Ittensohn OL; Bjerregaard MR
    Exp Cell Res; 1966 Apr; 42(1):157-70. PubMed ID: 5929562
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical correlates of responsiveness and collateral sensitivity of some methotrexate-resistant murine tumors to the lipophilic antifolate, metoprine.
    Sirotnak FM; Moccio DM; Goutas LJ; Kelleher LE; Montgomery JA
    Cancer Res; 1982 Mar; 42(3):924-8. PubMed ID: 7059991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.